UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
ONHEALTH NETWORK COMPANY
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
68272W-10-7
(CUSIP Number)
October 30, 1998
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
</PAGE>
SCHEDULE 13G
CUSIP NO. 68272W-10-7 PAGE 2 OF 9 PAGES
- - ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Advantage Fund II Ltd.
- - ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- - ------------------------------------------------------------------------- -
3 SEC USE ONLY
- - ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
- - ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 1,125,654
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
1,125,654
- - ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,125,654
- - ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- - ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.4%
- - ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
- - ------------------------------------------------------------------------- -
</PAGE>
SCHEDULE 13G
CUSIP NO. 68272W-10-7 PAGE 3 OF 9 PAGES
- - ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Genesee International, Inc.
- - ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- - ------------------------------------------------------------------------- -
3 SEC USE ONLY
- - ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- - ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 1,125,654
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
1,125,654
- - ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,125,654
- - ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- - ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.4%
- - ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
- - ------------------------------------------------------------------------- -
</PAGE>
SCHEDULE 13G
CUSIP NO. 68272W-10-7 PAGE 4 OF 9 PAGES
- - ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Donald R. Morken
- - ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- - ------------------------------------------------------------------------- -
3 SEC USE ONLY
- - ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- - ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 1,125,654
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
1,125,654
- - ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,125,654
- - ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- - ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.4%
- - ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- - ------------------------------------------------------------------------- -
</PAGE>
SCHEDULE 13G
CUSIP NO. 68272W-10-7 PAGE 5 OF 9 PAGES
Item 1. Name and Address of Issuer:
OnHealth Network Company
808 Howell Street
Suite 400
Seattle, Washington 98101
Item 2. (a) Names of Persons Filing:
Advantage Fund II Ltd. ("Advantage")
Genesee International, Inc. ("Genesee")
Donald R. Morken ("Mr. Morken")
(b) Address of Principal Business Office:
Advantage:
c/o CITCO
Kaya Flamboyan 9
Curacao, Netherlands Antilles
Genesee:
CITCO Building
Wickhams Cay
P.O. Box 662
Road Town
Tortola, British Virgin Islands
Mr. Morken:
10500 N.E. 8th Street
Suite 1920
Bellevue, Washington 98004-4332
(c) Place of Organization or Citizenship:
Advantage: a British Virgin Islands
corporation
Genesee: a Delaware corporation
Mr. Morken: a citizen of the United States
(d) Title of Class of Securities:
Common Stock, $.01 par value
(e) CUSIP Number:
68272W-10-7
Item 3. This statement is filed pursuant to Rule 13d-1(c) by
Advantage, Genesee and Mr. Morken.
</PAGE>
CUSIP NO. 68272W-10-7 PAGE 6 OF 9 PAGES
Item 4. Ownership:
(a) Amount Beneficially Owned by Advantage, Genesee
and Mr. Morken:
Advantage 1,125,654
Genesee 1,125,654
Mr. Morken 1,125,654
(b) Percent of Class:
Advantage 9.4%
Genesee 9.4%
Mr. Morken 9.4%
(c) Number of Shares as to which the Person has:
(i) sole power to vote or to direct the
vote
Advantage 0
Genesee 0
Mr. Morken 0
(ii) shared power to vote or to
direct the vote
Advantage 1,125,654
Genesee 1,125,654
Mr. Morken 1,125,654
(iii) sole power to dispose or to
direct the disposition of
Advantage 0
Genesee 0
Mr. Morken 0
(iv) shared power to dispose or to
direct the disposition of
Advantage 1,125,654
Genesee 1,125,654
Mr. Morken 1,125,654
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable
Item 6. Ownership of More Than Five Percent on Behalf of Another
Person:
Not applicable
</PAGE>
CUSIP NO. 68272W-10-7 PAGE 7 OF 9 PAGES
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security Being Reported on by the Parent
Holding Company:
Not applicable
Item 8. Identification and Classification of Members of the Group:
Not applicable
Item 9. Notice of Dissolution of Group:
Not applicable
Item 10. Certification:
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not
acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in
connection with or as a participant in any transaction
having that purpose or effect.
Exhibits:
1. Joint Filing Agreement, dated November 5, 1998, among Advantage,
Genesee and Mr. Morken.
</PAGE>
CUSIP NO. 68272W-10-7 PAGE 8 OF 9 PAGES
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
ADVANTAGE FUND II LTD.
By: /s/ W.R. Weber
Name: W.R. Weber
Title: President
Dated: November 5, 1998
GENESEE INTERNATIONAL, INC.
By: /s/ Donald R. Morken
Name: Donald R. Morken
Title: President
Dated: November 5, 1998
/s/ Donald R. Morken
Donald R. Morken
Dated: November 5, 1998
</PAGE>
CUSIP NO. 68272W-10-7 PAGE 9 OF 9 PAGES
Exhibit 1
---------
JOINT FILING AGREEMENT
----------------------
This will confirm the agreement by and among the undersigned that
the Schedule 13G filed with the Securities and Exchange Commission on or about
the date hereof with respect to the beneficial ownership of the undersigned of
shares of common stock of OnHealth Network Company, a Washington corporation,
is being filed, and all amendments thereto will be filed, on behalf of each of
the persons and entities named below in accordance with Rule 13d-1(k) under
the Securities Exchange Act of 1934, as amended. This Agreement may be
executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same
instrument.
Dated: November 5, 1998
ADVANTAGE FUND II LTD.
By: /s/ W.R. Weber
Name: W.R. Weber
Title: President
GENESEE INTERNATIONAL, INC.
By: /s/ Donald R. Morken
Name: Donald R. Morken
Title: President
/s/ Donald R. Morken
Donald R. Morken